Role of MEK-ERK pathway in morphine-induced conditioned place preference in ventral tegmental area of rats

Journal of Neuroscience Research

Volumn 88, Issue 7, 2010, Pages 1595-1604

  Lin, Xiaojing ^a   Wang, Qingsong ^a   Ji, Anguo ^a   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Conditioned place preference (CPP); ERK; Morphine; Opioid addiction; Proteomic analysis; Ventral tegmental area (VTA)

Indexed keywords

ADENYLATE KINASE; ALBUMIN; ALPHA INTERNEXIN; ALPHA TUBULIN; COFILIN 2; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CREATINE KINASE; FUMARATE HYDRATASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE REGULATED PROTEIN; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; KHELLIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MORPHINE; PROTEASOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG ABUSE; ENZYME ACTIVATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORPHINE ADDICTION; NEUROFILAMENT; NONHUMAN; PLACE PREFERENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; TWO DIMENSIONAL ELECTROPHORESIS; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ANIMALS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; MALE; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; RATS; RATS, WISTAR; VENTRAL TEGMENTAL AREA;

EID: 77952039996     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22326     Document Type: Article

References (49)

1. Beitner-Johnson D, Nestler EJ. 1991. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57:344-347.
2. Beitner-Johnson D, Guitart X, Nestler EJ. 1992. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J Neurosci 12:2165-2176.
3. Bierczynska-Krzysik A, Pradeep John JP, Silberring J, Kotlinska J, Dylag T, Cabatic M, Lubec G. 2006. Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med 18:775-784.
4. Bilecki W, Przewlocki R. 2000. Effect of opioids on Ca2+/cAMP responsive element binding protein. Acta Neurobiol Exp 60:557-567.
5. Chao J, Nestler EJ. 2004. Molecular neurobiology of drug addiction. Annu Rev Med 55:113-132.
6. Ferrer-Alcon M, Garcia-Fuster MJ, La Harpe R, Garcia-Sevilla JA. 2004. Long-term regulation of signaling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts. J Neurochem 90:220-230. (Pubitemid 38879176)
7. Fountoulakis M. 2004. Application of proteomics technologies in the investigation of the brain. Mass Spectrom Rev 23:231-258.
8. Hawes JJ, Narasimhaiah R, Picciotto MR. 2006. Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures. J Neurochem 96:1160-1168.
9. Jenab S, Festa ED, Nazarian A, Wu HB, Sun WL, Hazim R, Russo SJ, Quinones-Jenab V. 2005. Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. Brain Res Mol Brain Res 142:134-138. (Pubitemid 41681280)
10. Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ, Ho IK. 2005. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res 133:58-70. (Pubitemid 40136561)
11. Klitenick MA, DeWitte P, Kalivas PW. 1992. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci 12:2623-2632.
12. Koob GF, Sanna PP, Bloom FE. 1998. Neuroscience of addiction. Neuron 21:467-476.
13. Li JJ, Zhou X, Yu LC. 2005. Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation. Pain 118:232-242. (Pubitemid 41566604)
14. Li KW, Jimenez CR, van der Schors RC, Hornshaw MP, Schoffelmeer AN, Smit AB. 2006. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 6: 2003-2008.
15. Liu ML, Yu LC. 2008. Potential protection of green tea polyphenols against ultraviolet irradiation-induced injury on rat cortical neurons. Neurosci Lett 444:236-239.
16. Liu Y, He J, Ji S, Wang Q, Pu H, Jiang T, Meng L, Yang X, Ji J. 2008. Comparative studies of early liver dysfunction in senescence-accelerated mouse using mitochondrial proteomics approaches. Mol Cell Proteomics 7:1737-1747.
17. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y. 2004. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24:1604-1611. (Pubitemid 38240955)
18. Lu L, Koya E, Zhai H, Hope BT, Shaham Y. 2006. Role of ERK in cocaine addiction. Trends Neurosci 29:695-703.
19. Lubec G, Krapfenbauer K, Fountoulakis M. 2003. Proteomics in brain research: potentials and limitations. Prog Neurobiol 69:193-211. (Pubitemid 36577323)
20. Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R. 2001. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 14:1091-1104. (Pubitemid 35463753)
21. Mackler SA, Eberwine JH. 1994. Cellular adaptation to opiates alters ion-channel mRNA levels. Proc Natl Acad Sci USA 91:385-389.
22. Mamoon AM, Barnes AM, Ho IK, Hoskins B. 1995. Comparative rewarding properties of morphine and butorphanol. Brain Res Bull 38:507-511.
23. Marie-Claire C, Courtin C, Robert A, Gidrol X, Roques BP, Noble F. 2007. Sensitization to the conditioned rewarding effects of morphine modulates gene expression in rat hippocampus. Neuropharmacology 52:430-435. (Pubitemid 46137975)
24. Matus-Leibovitch N, Ezra-Macabee V, Saya D, Attali B, Avidor-Reiss T, Barg J, Vogel Z. 1995. Increased expression of synapsin I mRNA in defined areas of the rat central nervous system following chronic morphine treatment. Brain Res Mol Brain Res 34:221-230. (Pubitemid 26007078)
25. Mu P, Yu LC. 2007. Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. Neurosci Lett 426:135-138. (Pubitemid 47498719)
26. Muller DL, Unterwald EM. 2004. In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 310:774-782.
27. Narita M, Ioka M, Suzuki M, Suzuki T. 2002. Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain. Neurosci Lett 324:97-100. (Pubitemid 34457814)
28. Nestler EJ. 2004. Molecular mechanisms of drug addiction. Neuropharmacology 471:24-32.
29. Nestler EJ. 2005. Is there a common molecular pathway for addiction? Nat Neurosci 8:1445-1449.
30. Olmstead MC, Franklin KB. 1997. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav Neurosci 111:1324-1334. (Pubitemid 28010909)
31. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, Nestler EJ. 1995. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15:1285-1297.
32. Ozaki S, Narita M, Ozaki M, Khotib J, Suzuki T. 2004. Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation. J Neurochem 88:1389-1397. (Pubitemid 38366914)
33. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. Academic Press, Sydney.
34. Phillips AG, LePiane FG. 1980. Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav 12:965-968.
35. Prokai L, Zharikova AD, Stevens SM Jr. 2005. Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J Mass Spectrom 40:169-175. (Pubitemid 40327256)
36. Ren X, Noda Y, Mamiya T, Nagai T, Nabeshima T. 2004. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behav Brain Res 152:243-250. (Pubitemid 38757894)
37. Ribeiro Do Couto B, Aguilar MA, Rodriguez-Arias M, Minarro J. 2005. Long-lasting rewarding effects of morphine induced by drug primings. Brain Res 1050:53-63. (Pubitemid 40931926)
38. Self DW, Nestler EJ. 1998. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 51:49-60. (Pubitemid 28353755)
39. Shen Y, Yu LC. 2008. Potential protection of curcumin against hypoxia-induced decreases in beta-III tubulin content in rat prefrontal cortical neurons. Neurochem Res 33:2112-2117.
40. Torres G, Horowitz JM. 1999. Drugs of abuse and brain gene expression. Psychosom Med 61:630-650. (Pubitemid 29455086)
41. Tzschentke TM. 1998. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672.
42. Valverde O, Smadja C, Roques BP, Maldonado R. 1997. The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist. Psychopharmacology 131:79-85. (Pubitemid 27242858)
43. Wang B, Luo F, Zhang WT, Han JS. 2000. Stress or drug priming induces reinstatement of extinguished conditioned place preference. Neuroreport 11:2781-2784.
44. Wang Q, Liu Y, Zou X, An M, Guan X, He J, Tong Y, Ji J. 2008. The hippocampal proteomic analysis of senescence-accelerated mouse: implications of Uchl3 and mitofilin in cognitive disorder and mitochondria dysfunction in SAMP8. Neurochem Res 33:1776-1782.
45. Wise RA. 1998. Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22.
46. Xiong W, Yu LC. 2006. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats. Neurosci Lett 399:167-170.
47. Yang L, Sun ZS, Zhu YP. 2007. Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J Proteome Res 6:2239-2247. (Pubitemid 46985111)
48. Zhu H, Bilgin M, Snyder M. 2003. Proteomics. Annu Rev Biochem 72:783-812.
49. Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110. (Pubitemid 13058546)